Carcinoembryonic Antigen Increase in a Patient with Colon Cancer Who Have Achieved Complete Remission and Negative
calcitonin
carcinoembryonic antigen
colon adenocarcinoma
medullary thyroid carcinoma
Journal
Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503
Informations de publication
Date de publication:
05 08 2021
05 08 2021
Historique:
received:
18
06
2021
revised:
27
07
2021
accepted:
04
08
2021
entrez:
26
8
2021
pubmed:
27
8
2021
medline:
28
10
2021
Statut:
epublish
Résumé
Serum carcinoembryonic antigen (CEA) is a tumor marker especially used to follow a patient with colorectal cancer. However, it is non-specific and could be increased in several cancers and some benign conditions. We report the case of a 70-year-old man followed since 2014 for a left colon adenocarcinoma with the persistence of an increased CEA. There was no evidence of recurrence, but a right lobar thyroid nodule without a significantly increased uptake was incidentally discovered on the CT scan of
Identifiants
pubmed: 34436027
pii: curroncol28040261
doi: 10.3390/curroncol28040261
pmc: PMC8395414
doi:
Substances chimiques
Carcinoembryonic Antigen
0
Fluorodeoxyglucose F18
0Z5B2CJX4D
Calcitonin
9007-12-9
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2987-2992Références
Endocrine. 2012 Dec;42(3):535-45
pubmed: 22527889
Eur J Endocrinol. 2021 Jun 28;185(2):193-200
pubmed: 34010144
Eur Rev Med Pharmacol Sci. 2015;19(14):2634-40
pubmed: 26221894
Thyroid. 2021 Feb;31(2):151-155
pubmed: 33191866
JAMA. 2014 Jan 15;311(3):263-70
pubmed: 24430319
J Cancer Res Clin Oncol. 2020 Dec;146(12):3385-3388
pubmed: 32857179
Clin Endocrinol (Oxf). 2014 Dec;81(6):789-98
pubmed: 25056984
Ann Oncol. 2014 Sep;25 Suppl 3:iii1-9
pubmed: 25190710
Saudi J Kidney Dis Transpl. 2019 Jul-Aug;30(4):898-904
pubmed: 31464247
Surgery. 2017 Jan;161(1):137-146
pubmed: 27842913
World J Surg Oncol. 2017 Dec 29;15(1):230
pubmed: 29284496
J Med Case Rep. 2019 Aug 1;13(1):237
pubmed: 31366404
World J Surg. 2009 Jan;33(1):58-66
pubmed: 19005720
Int J Biol Markers. 2014 Jun 25;29(2):e184-6
pubmed: 24425322
Lung Cancer. 2012 May;76(2):138-43
pubmed: 22153832
Ann Hepatobiliary Pancreat Surg. 2017 Nov;21(4):243-246
pubmed: 29264590
Eur J Endocrinol. 2008 Feb;158(2):239-46
pubmed: 18230832
Clin Endocrinol (Oxf). 2004 Sep;61(3):299-310
pubmed: 15355445
J Coll Physicians Surg Pak. 2018 Dec;28(12):910-913
pubmed: 30501825
Clin J Gastroenterol. 2012 Apr;5(2):150-4
pubmed: 26182159
J Clin Endocrinol Metab. 2005 Nov;90(11):6077-84
pubmed: 16091497
Clin Endocrinol (Oxf). 2014 Jan;80(1):135-40
pubmed: 23627255
Intern Med. 2007;46(21):1795-8
pubmed: 17978537
BMJ Case Rep. 2018 Jun 11;2018:
pubmed: 29895542
J West Afr Coll Surg. 2017 Oct-Dec;7(4):120-127
pubmed: 30479994
Cancer. 2012 Feb 1;118(3):620-7
pubmed: 21717441
Onco Targets Ther. 2017 Sep 15;10:4591-4598
pubmed: 28979147
Ann Oncol. 2020 Oct;31(10):1291-1305
pubmed: 32702383
Cancers (Basel). 2020 Dec 30;13(1):
pubmed: 33396890
Clin Nucl Med. 2020 May;45(5):341-348
pubmed: 32049723
Clin Endocrinol (Oxf). 2019 Aug;91(2):340-347
pubmed: 31002419
Thyroid. 2015 Jun;25(6):567-610
pubmed: 25810047
World J Surg Oncol. 2018 Feb 12;16(1):26
pubmed: 29433529
Cochrane Database Syst Rev. 2015 Dec 10;(12):CD011134
pubmed: 26661580
Clin Endocrinol (Oxf). 2015 Feb;82(2):280-5
pubmed: 25047365
J Endocrinol Invest. 2021 Mar;44(3):587-597
pubmed: 32656666
Horm Metab Res. 2018 Jan;50(1):23-28
pubmed: 29169190
Thyroid. 2016 Nov;26(11):1563-1572
pubmed: 27604949
J Clin Endocrinol Metab. 2021 May 11;:
pubmed: 33974051
Cell. 1989 Apr 21;57(2):327-34
pubmed: 2702691
Dis Markers. 2018 May 2;2018:9863092
pubmed: 29854028